Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q3

4078.TEDINET S100ST22
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed

Amended by S100THLQ (2024-05-27).

Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥60.8bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥83.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥63.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥1.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥4.2bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.8bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥4.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.7bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥4.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥5.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥7.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥7.2bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥123.7bnat 2023-12-31Cons.Assets
Total assets¥128.0bnat 2023-03-31Cons.Assets
Total assets¥131.3bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥48.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥74.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥84.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥85.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥13.6bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥12.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-460.962023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-335.432023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥207.792022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.312022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio59.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥907m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥907m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2023-04-01 → 2023-12-31¥55.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥54.4bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥726m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2023-04-01 → 2023-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2023-04-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥181m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2023-04-01 → 2023-12-31¥260m
—segment totalrevenue2023-04-01 → 2023-12-31¥61.7bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥60.8bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥907m
—segment totalsegment profit2023-04-01 → 2023-12-31¥3.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥808m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.7bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-12-31¥58.1bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥57.5bn
jpcrp040300-q3r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥575m
jpcrp040300-q3r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥5.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥233m
jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥394m
—segment totalrevenue2022-04-01 → 2022-12-31¥64.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥63.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥808m
—segment totalsegment profit2022-04-01 → 2022-12-31¥5.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 376
ItemContextValueUnit
Gain on sales of golf memberships eiPrior1YTDDuration1000000JPY
Gain on sales of golf memberships eiCurrentYTDDuration－JPY
Insurance income eiPrior1YTDDuration378000000JPY
Insurance income eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration470000000JPY
Extraordinary incomeCurrentYTDDuration70000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration81000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration120000000JPY
Impairment loss elPrior1YTDDuration35000000JPY
Impairment loss elCurrentYTDDuration6256000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration7000000JPY
Extraordinary lossPrior1YTDDuration117000000JPY
Extraordinary lossCurrentYTDDuration6383000000JPY
Income before income taxesPrior1YTDDuration5042000000JPY
Income before income taxesCurrentYTDDuration-4536000000JPY
Income taxesPrior1YTDDuration1469000000JPY
Income taxesCurrentYTDDuration2679000000JPY
Profit lossPrior1YTDDuration3573000000JPY
Profit lossCurrentYTDDuration-7215000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration210000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration253000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration3363000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-7469000000JPY
Profit lossPrior1YTDDuration3573000000JPY
Profit lossCurrentYTDDuration-7215000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-122000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration746000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-61000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-21000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration928000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration595000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-0JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-12000000JPY
Other comprehensive incomePrior1YTDDuration744000000JPY
Other comprehensive incomeCurrentYTDDuration1308000000JPY
Comprehensive incomePrior1YTDDuration4317000000JPY
Comprehensive incomeCurrentYTDDuration-5907000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration3823000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-6289000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration493000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration382000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00780-000ChemicalReportableSegmentsMember57490000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E00780-000MedicineAndHealthCareReportableSegmentsMember6269000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember63759000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration63759000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00780-000ChemicalReportableSegmentsMember575000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E00780-000MedicineAndHealthCareReportableSegmentsMember233000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember808000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass